Ms. Carol E Kolek, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19 County Rd, Mattapoisette, MA 02739 Phone: 508-758-3754 Fax: 508-758-3755 |
News Archive
Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration. The application requests authorization to manufacture and market generic versions of REVLIMID (lenalidomide) 5, 10, 15 and 25 mg capsules in the United States.
The Wall Street Journal: A New Jersey court is weighing if the life of Ruben Betancourt "should have been prolonged and who should have made that decision: the hospital or his family." In a lawsuit, "his daughter, Jacqueline Betancourt, contends that her father was aware of his family's presence and that the hospital had no right to terminate life support without the family's agreement."
"At a two-day meeting organized and hosted by the World Health Organization (WHO) [in Geneva], 60 leaders in the field of global health statistics drew up a set of proposals to improve the world's ability to count the sick and the dead," ScienceInsider reports.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimized detachment zone for coils.
Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.
› Verified 7 days ago